The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the ro...
| Published in: | Cell Death and Disease |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2021-07-01
|
| Online Access: | https://doi.org/10.1038/s41419-021-03968-2 |
| _version_ | 1852801250268020736 |
|---|---|
| author | Long Gao Yuan Liu Xiaohong Du Sai Ma Minmin Ge Haijun Tang Chenfeng Han Xin Zhao Yanbin Liu Yun Shao Zhao Wu Lianjun Zhang Fang Meng F. Xiao-Feng Qin |
| author_facet | Long Gao Yuan Liu Xiaohong Du Sai Ma Minmin Ge Haijun Tang Chenfeng Han Xin Zhao Yanbin Liu Yun Shao Zhao Wu Lianjun Zhang Fang Meng F. Xiao-Feng Qin |
| author_sort | Long Gao |
| collection | DOAJ |
| container_title | Cell Death and Disease |
| description | Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the role of tumor expressed-CD38 on neoplastic formation and progression remains elusive. In the present study, we aimed to delineate the molecular and biochemical function of the tumor-associated CD38 in lung adenocarcinoma progression. Our clinical data showed that the upregulation of tumor-originated CD38 was correlated with poor survival of lung cancer patients. Using multiple in vitro assays we found that the enzymatic activity of tumor expressed-CD38 facilitated lung cancer cell migration, proliferation, colony formation, and tumor development. Consistently, our in vivo results showed that inhibition of the enzymatic activity or antagonizing the enzymatic product of CD38 resulted in the similar inhibition of tumor proliferation and metastasis as CD38 gene knock-out or mutation. At biochemical level, we further identified that cADPR, the mainly hydrolytic product of CD38, was responsible for inducing the opening of TRPM2 iron channel leading to the influx of intracellular Ca2+ and then led to increasing levels of NRF2 while decreasing expression of KEAP1 in lung cancer cells. These findings suggested that malignant lung cancer cells were capable of using cADPR catalyzed by CD38 to facilitate tumor progression, and blocking the enzymatic activity of CD38 could be represented as an important strategy for preventing tumor progression. |
| format | Article |
| id | doaj-art-a4e348d88b4e4e2b82f234dcd0f031e5 |
| institution | Directory of Open Access Journals |
| issn | 2041-4889 |
| language | English |
| publishDate | 2021-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| spelling | doaj-art-a4e348d88b4e4e2b82f234dcd0f031e52025-08-19T20:39:56ZengNature Publishing GroupCell Death and Disease2041-48892021-07-0112711310.1038/s41419-021-03968-2The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progressionLong Gao0Yuan Liu1Xiaohong Du2Sai Ma3Minmin Ge4Haijun Tang5Chenfeng Han6Xin Zhao7Yanbin Liu8Yun Shao9Zhao Wu10Lianjun Zhang11Fang Meng12F. Xiao-Feng Qin13Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Clinical Medicine Research, the Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Science and Technology Town HospitalInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the role of tumor expressed-CD38 on neoplastic formation and progression remains elusive. In the present study, we aimed to delineate the molecular and biochemical function of the tumor-associated CD38 in lung adenocarcinoma progression. Our clinical data showed that the upregulation of tumor-originated CD38 was correlated with poor survival of lung cancer patients. Using multiple in vitro assays we found that the enzymatic activity of tumor expressed-CD38 facilitated lung cancer cell migration, proliferation, colony formation, and tumor development. Consistently, our in vivo results showed that inhibition of the enzymatic activity or antagonizing the enzymatic product of CD38 resulted in the similar inhibition of tumor proliferation and metastasis as CD38 gene knock-out or mutation. At biochemical level, we further identified that cADPR, the mainly hydrolytic product of CD38, was responsible for inducing the opening of TRPM2 iron channel leading to the influx of intracellular Ca2+ and then led to increasing levels of NRF2 while decreasing expression of KEAP1 in lung cancer cells. These findings suggested that malignant lung cancer cells were capable of using cADPR catalyzed by CD38 to facilitate tumor progression, and blocking the enzymatic activity of CD38 could be represented as an important strategy for preventing tumor progression.https://doi.org/10.1038/s41419-021-03968-2 |
| spellingShingle | Long Gao Yuan Liu Xiaohong Du Sai Ma Minmin Ge Haijun Tang Chenfeng Han Xin Zhao Yanbin Liu Yun Shao Zhao Wu Lianjun Zhang Fang Meng F. Xiao-Feng Qin The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title | The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title_full | The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title_fullStr | The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title_full_unstemmed | The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title_short | The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression |
| title_sort | intrinsic role and mechanism of tumor expressed cd38 on lung adenocarcinoma progression |
| url | https://doi.org/10.1038/s41419-021-03968-2 |
| work_keys_str_mv | AT longgao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yuanliu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT xiaohongdu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT saima theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT minminge theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT haijuntang theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT chenfenghan theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT xinzhao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yanbinliu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yunshao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT zhaowu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT lianjunzhang theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT fangmeng theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT fxiaofengqin theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT longgao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yuanliu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT xiaohongdu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT saima intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT minminge intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT haijuntang intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT chenfenghan intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT xinzhao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yanbinliu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT yunshao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT zhaowu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT lianjunzhang intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT fangmeng intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression AT fxiaofengqin intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression |
